{"id":"https://openalex.org/W1998588975","doi":"https://doi.org/10.1111/j.1365-3083.1987.tb01075.x","title":"Cytotoxic Human HLA Class II Restricted Purified Protein Derivative\u2010Reactive T\u2010Lymphocyte Clones","display_name":"Cytotoxic Human HLA Class II Restricted Purified Protein Derivative\u2010Reactive T\u2010Lymphocyte Clones","publication_year":1987,"publication_date":"1987-03-01","ids":{"openalex":"https://openalex.org/W1998588975","doi":"https://doi.org/10.1111/j.1365-3083.1987.tb01075.x","mag":"1998588975","pmid":"https://pubmed.ncbi.nlm.nih.gov/3494302"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-3083.1987.tb01075.x","doi":"https://doi.org/10.1111/j.1365-3083.1987.tb01075.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-3083.1987.tb01075.x","pdf_url":null,"source":{"id":"https://openalex.org/S79173686","display_name":"Scandinavian Journal of Immunology","issn_l":"0300-9475","issn":["0300-9475","1365-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039225894","display_name":"Peter Wendelboe Hansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800392737","display_name":"Aarhus Municipality","ror":"https://ror.org/02wwbem66","country_code":"DK","type":"government","lineage":["https://openalex.org/I2800392737"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"P. W. HANSEN","raw_affiliation_strings":["Department of Clinical Immunology, The Tissue Typing Laboratory, Aarhus Kommunehospital. Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, The Tissue Typing Laboratory, Aarhus Kommunehospital. Aarhus, Denmark","institution_ids":["https://openalex.org/I2800392737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104858094","display_name":"Claus Munck Petersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800392737","display_name":"Aarhus Municipality","ror":"https://ror.org/02wwbem66","country_code":"DK","type":"government","lineage":["https://openalex.org/I2800392737"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"C. MUNCK PETERSEN","raw_affiliation_strings":["Department of Clinical Immunology, The Tissue Typing Laboratory, Aarhus Kommunehospital. Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, The Tissue Typing Laboratory, Aarhus Kommunehospital. Aarhus, Denmark","institution_ids":["https://openalex.org/I2800392737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035317991","display_name":"Johan V. Povlsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800392737","display_name":"Aarhus Municipality","ror":"https://ror.org/02wwbem66","country_code":"DK","type":"government","lineage":["https://openalex.org/I2800392737"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"J. VESTERG\u00c5RD POVLSEN","raw_affiliation_strings":["Department of Clinical Immunology, The Tissue Typing Laboratory, Aarhus Kommunehospital. Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, The Tissue Typing Laboratory, Aarhus Kommunehospital. Aarhus, Denmark","institution_ids":["https://openalex.org/I2800392737"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012029324","display_name":"Tom Kristensen","orcid":"https://orcid.org/0000-0002-2131-4469","observed_orcids":["https://orcid.org/0000-0002-2131-4469"]},"institutions":[{"id":"https://openalex.org/I2800392737","display_name":"Aarhus Municipality","ror":"https://ror.org/02wwbem66","country_code":"DK","type":"government","lineage":["https://openalex.org/I2800392737"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"T. KRISTENSEN","raw_affiliation_strings":["Department of Clinical Immunology, The Tissue Typing Laboratory, Aarhus Kommunehospital. Aarhus, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, The Tissue Typing Laboratory, Aarhus Kommunehospital. Aarhus, Denmark","institution_ids":["https://openalex.org/I2800392737"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5039225894"],"corresponding_institution_ids":["https://openalex.org/I2800392737"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":null,"fwci":1.0243,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.76290457,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"3","first_page":"295","last_page":"303"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.8657000064849854,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.8657000064849854,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.07639999687671661,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.018699999898672104,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/purified-protein-derivative","display_name":"purified protein derivative","score":0.8420000076293945},{"id":"https://openalex.org/keywords/tuberculin","display_name":"tuberculin","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.9070000052452087},{"id":"https://openalex.org/keywords/hla-class-ii-restriction","display_name":"HLA class II restriction","score":0.9520000219345093},{"id":"https://openalex.org/keywords/hla-dr2","display_name":"HLA-DR2","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hla-dr1","display_name":"HLA-DR1","score":0.7039999961853027},{"id":"https://openalex.org/keywords/t-cell-clones","display_name":"T cell clones","score":0.5839999914169312},{"id":"https://openalex.org/keywords/mycobacterial-antigens","display_name":"mycobacterial antigens","score":0.8479999899864197},{"id":"https://openalex.org/keywords/alloreactivity","display_name":"alloreactivity","score":0.7620000243186951}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.8405447006225586},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.6919161081314087},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5341647267341614},{"id":"https://openalex.org/C2992881475","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T lymphocyte","level":3,"score":0.46580344438552856},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4629683494567871},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.42385274171829224},{"id":"https://openalex.org/C2777212361","wikidata":"https://www.wikidata.org/wiki/Q5127848","display_name":"Class (philosophy)","level":2,"score":0.422408789396286},{"id":"https://openalex.org/C2910580931","wikidata":"https://www.wikidata.org/wiki/Q29505","display_name":"Purified protein derivative","level":4,"score":0.4109065532684326},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4083905816078186},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34847819805145264},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.3194003701210022},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.28199416399002075},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20841103792190552},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.13872340321540833},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.10469919443130493},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08350729942321777},{"id":"https://openalex.org/C2776247216","wikidata":"https://www.wikidata.org/wiki/Q29505","display_name":"Tuberculin","level":3,"score":0.0},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0},{"id":"https://openalex.org/C106159729","wikidata":"https://www.wikidata.org/wiki/Q2294553","display_name":"Financial economics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000938","descriptor_name":"Antigen-Presenting Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000942","descriptor_name":"Antigens, Bacterial","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000942","descriptor_name":"Antigens, Bacterial","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002999","descriptor_name":"Clone Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006680","descriptor_name":"HLA Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006681","descriptor_name":"HLA-D Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009161","descriptor_name":"Mycobacterium","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014373","descriptor_name":"Tuberculin","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014373","descriptor_name":"Tuberculin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1365-3083.1987.tb01075.x","doi":"https://doi.org/10.1111/j.1365-3083.1987.tb01075.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-3083.1987.tb01075.x","pdf_url":null,"source":{"id":"https://openalex.org/S79173686","display_name":"Scandinavian Journal of Immunology","issn_l":"0300-9475","issn":["0300-9475","1365-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:3494302","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3494302","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scandinavian journal of immunology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:publications/0dce16b4-1f93-4e7d-b686-19f7465adfcb","doi":null,"is_oa":false,"landing_page_url":"https://pure.au.dk/portal/en/publications/0dce16b4-1f93-4e7d-b686-19f7465adfcb","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hansen, P W, Petersen, C M, Povlsen, J V & Kristensen, T 1987, 'Cytotoxic human HLA class II restricted purified protein derivative-reactive T-lymphocyte clones. IV. Analysis of HLA restriction pattern and mycobacterial antigen specificity', Scandinavian Journal of Immunology, vol. 25, no. 3, pp. 295-303.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W799452","https://openalex.org/W1483035379","https://openalex.org/W1514474730","https://openalex.org/W1567806359","https://openalex.org/W1570160775","https://openalex.org/W1966300007","https://openalex.org/W1973184851","https://openalex.org/W1985597900","https://openalex.org/W1985774274","https://openalex.org/W1986309700","https://openalex.org/W1988574276","https://openalex.org/W1988606049","https://openalex.org/W1993064155","https://openalex.org/W1998677849","https://openalex.org/W1999235534","https://openalex.org/W2011827552","https://openalex.org/W2013973256","https://openalex.org/W2024879535","https://openalex.org/W2026970642","https://openalex.org/W2040289923","https://openalex.org/W2041575832","https://openalex.org/W2052023452","https://openalex.org/W2063988753","https://openalex.org/W2069703570","https://openalex.org/W2071779077","https://openalex.org/W2077202178","https://openalex.org/W2077210656","https://openalex.org/W2084098587","https://openalex.org/W2084823211","https://openalex.org/W2121484459","https://openalex.org/W2152448943","https://openalex.org/W2155784158","https://openalex.org/W2168876902","https://openalex.org/W2400896855","https://openalex.org/W2407374394","https://openalex.org/W2474195739","https://openalex.org/W4246904433"],"related_works":["https://openalex.org/W2146805638","https://openalex.org/W1973184851","https://openalex.org/W1965917473","https://openalex.org/W2152448943","https://openalex.org/W2506984574","https://openalex.org/W1486694133","https://openalex.org/W2011827552","https://openalex.org/W2086280789","https://openalex.org/W1586305848","https://openalex.org/W2066906472"],"abstract_inverted_index":{"Human":[0],"T-lymphocyte":[1],"clones":[2,37,68,91,141,163],"specific":[3],"for":[4],"antigenic":[5],"components":[6],"of":[7,12,35,51,87,139,156,168],"purified":[8],"protein":[9],"derivative":[10],"(PPD)":[11],"tuberculin":[13],"were":[14,39,69,92],"generated":[15],"by":[16,71,77,82,128,144],"limiting":[17],"dilution":[18],"using":[19,145],"in":[20,99],"vitro":[21],"PPD-activated":[22],"peripheral":[23],"blood":[24],"mononuclear":[25],"cells":[26],"from":[27,153],"a":[28,49,154],"single":[29],"donor.":[30,89],"The":[31,136],"HLA":[32,72],"restriction":[33],"specificity":[34,138],"eight":[36],"that":[38,120],"cytotoxic":[40,64,105],"against":[41,48,107,132],"autologous":[42,146],"PPD-pulsed":[43],"monocyte":[44,147],"targets,":[45],"was":[46,116,121,126,142],"examined":[47],"panel":[50],"allogeneic":[52],"PPD":[53],"pulsed":[54,149],"targets.":[55],"In":[56,109,171],"agreement":[57],"with":[58,61,150,165,178],"our":[59],"findings":[60],"bulk-expanded":[62],"PPD-reactive":[63],"T":[65],"lymphocytes,":[66],"all":[67],"restricted":[70],"class":[73],"II":[74],"antigens:":[75],"seven":[76,161],"HLA-DR":[78,85,134],"2":[79],"and":[80],"one":[81,119],"HLA-DRw10--the":[83],"other":[84],"antigen":[86,137,180],"the":[88,113,117,140,166,173],"All":[90,160],"CD3+,":[93],"CD4+,":[94],"CD8-.":[95],"One":[96],"clone":[97,115,175],"exhibited,":[98],"addition":[100],"to":[101,182],"HLA-DR2":[102],"restriction,":[103],"unrestricted":[104],"alloreactivity":[106],"HLA-DR1.":[108],"monoclonal":[110,130],"antibody-blocking":[111],"experiments":[112],"latter":[114],"only":[118],"blocked.":[122],"Its":[123],"lytic":[124],"ability":[125],"abolished":[127],"two":[129],"antibodies":[131],"monomorphic":[133],"determinants.":[135],"studied":[143],"targets":[148],"antigens":[151,169],"prepared":[152],"range":[155],"different":[157],"mycobacterial":[158],"species.":[159],"HLA-DR2-restricted":[162],"reacted":[164,176],"majority":[167],"tested.":[170],"contrast,":[172],"HLA-DRw10-restricted":[174],"exclusively":[177],"an":[179],"unique":[181],"PPD.":[183]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}